Abstract
death. Treg do not only inhibit autoimmunity, they also inhibit or fine-regulate immunity to tumors and infection, and prevent inflammatory bowel disease in mice. These cells are also involved in transplantation tolerance; they can inhibit Graft-versus-host disease as well as allograft rejection (1) (2) (3) (4) (5) (6) .
Given the potent immunomodulatory potential of Treg, it is not very surprising that they have recently received a lot of attention. However, not a lot is known about their development.
Treg differentiate in the thymus (7) and MHC class II expression by cortical epithelial cells is sufficient for their positive selection (8) . Deletion of autospecific Treg can be induced by APC of bone-marrow origin (9, 10) . These two features of thymic Treg selection cannot explain their autoreactive repertoire (9, 11, 12) . However, as compared to conventional T cell precursors, Treg precursors appear to be more resistant to deletion induced by epithelial cells (13) (14) (15) . Moreover, in peripheral lymphoid organs autospecific Treg proliferate (11, (16) (17) (18) (19) 
Antibodies
The following antibodies and secondary reagents were used for phenotypic analysis: FITC, PE-Cy7, Pacific Blue or APC-labeled anti-CD4 (GK1.5), FITC, Alexa Fluor 700 or APC- 
Bone-marrow chimeras
Bone-marrow from femurs and tibias was collected in DMEM medium supplemented with 10% FCS. Thy1-expressing cells were eliminated using AT83 (anti-Thy1.1) or HO.22.1.1
(anti-Thy1.1) culture supernatants and rabbit complement (Saxon, HD supplies, Aylesbury, Bucks, UK). Cells from each donor were injected intravenously into lethally γ-irradiated hosts (8.5 Gy; 137 Cs source, 6.3 Gy/min) that were kept on antibiotic-containing water (0.2% of bactrim; Roche, Basel, Switzerland) for the complete duration of the experiment (6 weeks).
Flow cytometry
Thymocytes , splenocytes or lymph node cells were incubated 30 min on ice in 2.4G2 (anti- 
BrdU incorporation studies
For analysis of kinetics of thymic T cell development, mice were continuously exposed to the thymidine analogue bromodeoxyuridine (0.8 mg/mL) in their drinking water for various times. Extracellular staining of thymocytes with mAbs against CD4, CD8 and CD25 was performed as described above. Cells were subsequently fixed, permeabilized and stained with FITC-labeled anti-BrdU antibody using the BrdU Flow Kit (BD Pharmingen, Heidelberg, Germany). 
Proliferation assays

CD4
Microsatellite markers and genotyping
Genomic DNA was prepared from tail tips using High Pure PCR Template Preparation kit (Roche). Microsatellite markers are referenced in the Mouse Genome Database, release 3.5
(available from www.informatics.jax.org). PCR amplifications were performed in a T3
thermocycler (Biometra, Göttingen, Germany) in 20 µL volumes using 100 ng genomic DNA, figure 1B we observed considerable differences between several of these inbred mouse strains.
A locus closely linked to the MHC controls regulatory T cell development in the thymus
We next investigated the potential implication of the MHC locus in the modulation of CD4SP CD25 high thymocyte development (Fig. 2) . Congenic B10.BR mice carry the C57BR-derived MHC locus of H-2 k haplotype on a B10 genetic background. Interestingly, these mice had as high levels of thymic CD4SP CD25 high cells as the C57BR donor strain ( Fig. 2A) , directly implicating an MHC-linked locus in the modulation of thymic regulatory T cell development.
We next analyzed the proportion of CD25 high cells among CD4SP thymocytes in the congenic BALB.K strain, also carrying an MHC locus of H-2 k haplotype, but on the BALB/c genetic background. Again, high levels of CD25 high cells were found among CD4SP thymocytes ( Fig.   2A) . Interestingly, the MHC locus carried by BALB.K mice is of C3H origin, and the latter strain actually has significantly lower percentages of CD25 high cells than BALB.K mice ( Fig.   2A ). This result indicates that the C3H-derived MHC locus contains a gene allowing for development of high numbers of Treg (in BALB.K mice), and that in C3H mice non MHClinked genes neutralize the Treg development-promoting effect of this locus. BALB/c mice corresponded to increased Treg/DP ratios, indicating increased differentiation of CD25 high cells from DP precursors (Fig. 2B) . No differences were observed between the ratios of CD4SP CD25 -to DP thymocytes in the mouse strains analyzed (Fig. 2B) . Combined, these results indicate that the MHC locus of H-2 k haplotype contains a gene (or genes) that significantly modulates regulatory T cell development.
MHC class II molecules are not responsible for the modulation of Treg development
Potential candidates for genes residing in the MHC locus and modulating thymic Treg development are the MHC class II genes, which are required for Treg differentiation. The potential implication of MHC class II genes was assessed in two different manners.
We first analyzed recombinant congenic mouse lines (Fig. 2C) Secondly, we assessed if the gene(s) responsible for modulation of thymic Treg development act in a thymocyte intrinsic or extrinsic manner (Fig. 3) . To this end, we generated radiation bone-marrow chimeras by reconstituting H-2 bk hosts with a mixture of B6.Thy1.1 and C57BR (Thy1.2) bone marrow. Six weeks later thymocytes were analyzed by flow-cytometry using the Thy1 allelic marker to distinguish between the two types of donor cells. In these chimeras, in which B6 and C57BR thymocytes developed in an identical thymic microenvironment, significantly more CD25 high cells developed from C57BR than from B6 precursors (Fig. 3A) .
Similar results were obtained with single and mixed bone marrow chimeras made using B10.BR and B6 bone marrow (Fig. 3B) . These results show that thymocyte-intrinsic factors considerably modulate thymic Treg development. They therefore confirm that MHC class II molecules are not responsible for the distinct percentages of mature thymic Treg observed in the mouse strains studied.
A genetic locus responsible for modulation of thymic Treg development is located in a ≤2.2
Mbp region telomeric to the MHC
The data presented here show that an MHC-linked locus contains (a) gene(s) capable of modulating Treg development in the thymus. Our comparison of B10.A and B10.A(2R)
congenic mice indicates that a responsible gene must be located in or near the telomeric region of the MHC (34). We wished to more precisely define this region and performed microsatellite analyses of several congenic mouse strains (Table I) . As reported previously, B10.A(2R) congenics had lost a telomeric part of the introgressed strain A region in B10.A mice. This region of interest (cf. Fig. 2C ), delimited by D17Mit214 and 148, was included in the introgressed regions of B10.BR and BALB.K mice. These data suggest that the "high Treg" phenotype of B10.A, B10.BR, and BALB.K mice may be due to the same gene(s).
We have previously published that Treg development is also quantitatively modulated by non MHC-linked loci (32). In B10.S and B10.D2 congenic strains, decisive genes are located outside the introgressed donor regions. To define if the locus identified in the present report is distinct from those non MHC-linked regions, we performed microsatellite analysis of part of chromosome 17 from B10.S and B10.D2 mice ( analyzed the appearance of BrdU-labeled Treg (Fig. 4) . More BrdU + CD25 high cells were found among B10.BR than among B6 CD4SP thymocytes, while no difference was found for CD4SP CD25 -cells (Fig. 4) . These data show that the difference in the proportion of CD25 high cells among CD4SP thymocytes is at least in part due to differences in their differentiation.
However, formally we cannot exclude the possibility that a difference in thymic retention of Treg also plays a role.
Regulatory T lymphocytes from low and high producer strains are phenotypically and functionally equivalent
We next investigated if the mature CD4SP CD25 + thymocytes developing in the distinct mouse strains were identical. Flow-cytometry analysis revealed that the phenotype of mature regulatory T cells in B6, B10.BR, and C57BR mice was identical (Fig. 5A) (Fig. 6 ). Mixed bone marrow chimeras were generated by reconstituting lethally irradiated hosts with a mixture of B6.Thy1.1 and B10.BR (Thy1.2) bone marrow. Six weeks later thymocytes from these chimeras were analyzed using the allelic Thy1 marker to distinguish between the two types of donor bone marrow injected. As shown in figure 6 , substantially more Foxp3 + CD4SP thymocytes were observed among B10.BR than among B6 thymocytes.
Since no markers are available to distinguish between BALB/c and BALB.K CD4SP thymocytes, we generated two types of bone marrow chimeras. Lethally irradiated hosts were reconstituted with B6.Thy1.1 plus BALB/c or BALB.K (Thy1.2) bone marrow. Thymocytes from these chimeras were analyzed six weeks later. In both types of chimeras identical percentages of Foxp3 + CD4SP cells among B6 thymocytes were found (Fig. 6) . BALB.K thymocytes contained substantially more Foxp3 + CD4SP Treg than BALB/c thymocytes.
These data show that development of Foxp3 + regulatory T lymphocytes is modulated by polymorphic genes linked to the MHC locus. 
The percentages of thymic and peripheral Foxp3
Discussion
In this report, we showed that genetic factors modulate thymic development of regulatory T cells in a quantitatively very substantial fashion. Responsible genes act in a thymocyteintrinsic manner and modulate the differentiation of Treg from their immature precursors.
Importantly, we mapped the locus involved to a ≤ 2.2 Mbp region telomeric to the MHC, definitively excluding a role for MHC class II genes.
Our data indicate that MHC-linked genes very substantially modulate thymic differentiation At least three of the studied mouse strains (C3H, CBA, and B10.BR) carrying an MHC-linked gene allowing for development of high numbers of Treg are reference models for
Experimental Autoimmune Thyroiditis (36, 37) . Since levels of thymic and peripheral Foxp3 + Treg are directly correlated, it is tempting to speculate that the responsible gene would somehow be involved in susceptibility to autoimmunity. However, C3H mice also carry another gene that inhibits expression of the thymic phenotype of the MHC-linked gene.
Therefore, we do not think that the responsible gene would affect susceptibility to autoimmune disease for simple quantitative reasons. Rather, since it acts in a T cell-intrinsic manner, the responsible gene could somehow influence peripheral function of Treg, e.g. by affecting TCR-repertoire, homing, adhesion, or TCR-signal transduction. Identification of such differences will first require identification of the responsible gene(s) and then generation and extensive analysis of genetically modified mice. It will also be of considerable interest to study Treg development in other mouse-models for autoimmune-disease.
Here we showed that percentages of thymic and peripheral Foxp3 + Treg were directly correlated. In contrast, levels of thymic and peripheral CD25 high Treg did not correlate. This observation is, at least in part, explained by our observation that substantial differences exist between the fraction of Foxp3 + cells expressing high levels of CD25 in the thymus and the periphery (not shown). CD25-expression by Treg has previously been shown to be unstable in vivo (38) . It will be of interest to study the factors determining CD25-expression by Treg in vivo.
Identification of the responsible gene(s) will also be important to study regulatory T cell 
